American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
48.17
+1.35 (2.88%)
At close: Feb 5, 2026, 4:00 PM EST
47.20
-0.97 (-2.01%)
After-hours: Feb 5, 2026, 7:59 PM EST
American Healthcare REIT Stock Forecast
Stock Price Forecast
The 11 analysts that cover American Healthcare REIT stock have a consensus rating of "Buy" and an average price target of $52, which forecasts a 7.95% increase in the stock price over the next year. The lowest target is $37 and the highest is $60.
Price Target: $52 (+7.95%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for American Healthcare REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 6 | 6 | 6 | 6 | 7 | 7 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Reiterates $60 | Buy | Reiterates | $60 | +24.56% | Feb 5, 2026 |
| BMO Capital | BMO Capital | Buy Initiates $55 | Buy | Initiates | $55 | +14.18% | Jan 29, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $53 → $52 | Strong Buy | Maintains | $53 → $52 | +7.95% | Jan 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $46 → $53 | Strong Buy | Maintains | $46 → $53 | +10.03% | Nov 26, 2025 |
| Citigroup | Citigroup | Hold Maintains $45 → $52 | Hold | Maintains | $45 → $52 | +7.95% | Nov 21, 2025 |
Financial Forecast
Revenue This Year
2.28B
from 2.06B
Increased by 10.28%
Revenue Next Year
2.53B
from 2.28B
Increased by 11.03%
EPS This Year
0.47
from -0.24
EPS Next Year
0.73
from 0.47
Increased by 54.04%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.4B | 2.9B | ||||
| Avg | 2.3B | 2.5B | ||||
| Low | 2.2B | 2.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 17.8% | 27.2% | ||||
| Avg | 10.3% | 11.0% | ||||
| Low | 4.4% | -0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.56 | 0.83 | |
| Avg | 0.47 | 0.73 | |
| Low | 0.32 | 0.57 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 74.7% | |
| Avg | - | 54.0% | |
| Low | - | 19.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.